5 Questions with MARAbio Founder & Chief Science Advisor, Dr. Judy Van de Water Breakthroughs in the study of a sub-type of autism are powering a new area of precision-medicine to change the future of autism. MARAbio’s pioneering Founder & Chief Science Advisor shares her thoughts on what’s at stake and what’s in store. Guest […]
A market ripe for digital disruption in the 21st century Guest Post by Diana Hall, President and CEO of ActivArmor Fracture care has revolved around one solution for thousands of years: an application by wrapping wet material, like cotton, with plaster or fiberglass that hardens while drying – called “casting.” Throughout history, there have been […]
Guest Post by Michael G. Nathans, CEO and Co-Founder at WhisperSom Corporation Researchers have found that diabetes and ADHD in children as well as heart attacks, strokes, and Alzheimer’s Disease in adults are linked to unmanaged sleep apnea. Why? Because regular breathing while asleep is as important as having a regular heartbeat—and sleep apnea disrupts a person’s […]
Guest Post by Andrew Dahl of NOXBOX Concussions are a mild to moderate traumatic brain injury (TBI) that can have serious long-term effects on the brain. The effects of a concussion can range from mild to severe and can last for days, weeks, or even months. Unfortunately, concussions are often difficult to diagnose. Delayed concussion […]
Funded by multiple grants, alum Russ Lehrman (PhD ‘81) is developing a new therapeutic to revolutionize pulmonary care, starting with preterm infants Guest Post By Brianna Foth Respiratory disease and related complications are a leading cause of illness and death in the United States, collectively costing the health system more than $170 billion annually. Respiratory disease […]
Written by Andrew Dahl, CEO of NOXBOX Concussions are a serious problem in the U.S., but they’re not well understood by the general public. The Centers for Disease Control and Prevention estimates that 7.8 million concussions occur annually in the United States alone, but it’s likely another 7.8 million go unreported. This is a conservative […]
Site Disclaimer
By using this website (the “Site”), you are subject to our Terms of Use and our Privacy Policy. Please read these carefully before proceeding. The Discovery page offers users the opportunity to preview early-stage companies, which may be under consideration for fundraising on the RedCrow INVEST platform. These companies are not currently raising capital on our Site, and we may not have performed any due diligence or verified that the information they’ve posted is accurate. Companies actively raising money on our Site are listed on the INVEST platform. RedCrow is not an investment adviser. Listings on the RedCrow site do not imply a recommendation or endorsement by RedCrow.
